These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
277 related articles for article (PubMed ID: 9394024)
1. Cytochrome P450 isozymes involved in lisofylline metabolism to pentoxifylline in human liver microsomes. Lee SH; Slattery JT Drug Metab Dispos; 1997 Dec; 25(12):1354-8. PubMed ID: 9394024 [TBL] [Abstract][Full Text] [Related]
2. [O-methyl 14C]naproxen O-demethylase activity in human liver microsomes: evidence for the involvement of cytochrome P4501A2 and P4502C9/10. Rodrigues AD; Kukulka MJ; Roberts EM; Ouellet D; Rodgers TR Drug Metab Dispos; 1996 Jan; 24(1):126-36. PubMed ID: 8825200 [TBL] [Abstract][Full Text] [Related]
3. CYP3A4-mediated oxidation of lisofylline to lisofylline 4,5-diol in human liver microsomes. Shin HS; Slattery JT J Pharm Sci; 1998 Mar; 87(3):390-3. PubMed ID: 9523995 [TBL] [Abstract][Full Text] [Related]
4. Identification of the human liver microsomal cytochrome P450s involved in the metabolism of N-nitrosodi-n-propylamine. Teiber JF; Hollenberg PF Carcinogenesis; 2000 Aug; 21(8):1559-66. PubMed ID: 10910959 [TBL] [Abstract][Full Text] [Related]
5. A predominate role of CYP1A2 for the metabolism of nabumetone to the active metabolite, 6-methoxy-2-naphthylacetic acid, in human liver microsomes. Turpeinen M; Hofmann U; Klein K; Mürdter T; Schwab M; Zanger UM Drug Metab Dispos; 2009 May; 37(5):1017-24. PubMed ID: 19204080 [TBL] [Abstract][Full Text] [Related]
6. Metabolic activation of dacarbazine by human cytochromes P450: the role of CYP1A1, CYP1A2, and CYP2E1. Reid JM; Kuffel MJ; Miller JK; Rios R; Ames MM Clin Cancer Res; 1999 Aug; 5(8):2192-7. PubMed ID: 10473105 [TBL] [Abstract][Full Text] [Related]
7. Role of human microsomal and human complementary DNA-expressed cytochromes P4501A2 and P4503A4 in the bioactivation of aflatoxin B1. Gallagher EP; Wienkers LC; Stapleton PL; Kunze KL; Eaton DL Cancer Res; 1994 Jan; 54(1):101-8. PubMed ID: 8261428 [TBL] [Abstract][Full Text] [Related]
8. Metabolism of Zaleplon by human hepatic microsomal cytochrome P450 isoforms. Renwick AB; Mistry H; Ball SE; Walters DG; Kao J; Lake BG Xenobiotica; 1998 Apr; 28(4):337-48. PubMed ID: 9604298 [TBL] [Abstract][Full Text] [Related]
9. Selectivities of human cytochrome P450 inhibitors toward rat P450 isoforms: study with cDNA-expressed systems of the rat. Kobayashi K; Urashima K; Shimada N; Chiba K Drug Metab Dispos; 2003 Jul; 31(7):833-6. PubMed ID: 12814958 [TBL] [Abstract][Full Text] [Related]
10. The kinetics of aflatoxin B1 oxidation by human cDNA-expressed and human liver microsomal cytochromes P450 1A2 and 3A4. Gallagher EP; Kunze KL; Stapleton PL; Eaton DL Toxicol Appl Pharmacol; 1996 Dec; 141(2):595-606. PubMed ID: 8975785 [TBL] [Abstract][Full Text] [Related]
11. Oxidation of cyclophosphamide to 4-hydroxycyclophosphamide and deschloroethylcyclophosphamide in human liver microsomes. Ren S; Yang JS; Kalhorn TF; Slattery JT Cancer Res; 1997 Oct; 57(19):4229-35. PubMed ID: 9331082 [TBL] [Abstract][Full Text] [Related]
12. Metabolic activation of o-phenylphenol to a major cytotoxic metabolite, phenylhydroquinone: role of human CYP1A2 and rat CYP2C11/CYP2E1. Ozawa S; Ohta K; Miyajima A; Kurebayashi H; Sunouchi M; Shimizu M; Murayama N; Matsumoto Y; Fukuoka M; Ohno Y Xenobiotica; 2000 Oct; 30(10):1005-17. PubMed ID: 11315102 [TBL] [Abstract][Full Text] [Related]
13. Metabolism of dexfenfluramine in human liver microsomes and by recombinant enzymes: role of CYP2D6 and 1A2. Haritos VS; Ching MS; Ghabrial H; Gross AS; Taavitsainen P; Pelkonen O; Battaglia SE; Smallwood RA; Ahokas JT Pharmacogenetics; 1998 Oct; 8(5):423-32. PubMed ID: 9825834 [TBL] [Abstract][Full Text] [Related]
14. Involvement of CYP2E1 as A low-affinity enzyme in phenacetin O-deethylation in human liver microsomes. Kobayashi K; Nakajima M; Oshima K; Shimada N; Yokoi T; Chiba K Drug Metab Dispos; 1999 Aug; 27(8):860-5. PubMed ID: 10421611 [TBL] [Abstract][Full Text] [Related]
15. Evidence for the involvement of human liver microsomes CYP1A2 in the mono-hydroxylation of daidzein. Peng WX; Wang LS; Li HD; Abd El-Aty AM; Chen GL; Zhou HH Clin Chim Acta; 2003 Aug; 334(1-2):77-85. PubMed ID: 12867277 [TBL] [Abstract][Full Text] [Related]
16. Metabolism of a novel phosphodiesterase-IV inhibitor (V11294) by human hepatic cytochrome P450 forms. Subrahmanyam V; Renwick AB; Walters DG; Price RJ; Tonelli AP; Lake BG Xenobiotica; 2002 Jun; 32(6):521-34. PubMed ID: 12160484 [TBL] [Abstract][Full Text] [Related]
17. Cytochrome P450 isoform inhibitors as a tool for the investigation of metabolic reactions catalyzed by human liver microsomes. Bourrié M; Meunier V; Berger Y; Fabre G J Pharmacol Exp Ther; 1996 Apr; 277(1):321-32. PubMed ID: 8613937 [TBL] [Abstract][Full Text] [Related]
18. Identification of the human liver cytochrome P450 isoenzymes responsible for the 5-methylhydroxylation of the novel anti-fibrotic drug AKF-PD. He X; Luo X; Liu Z; Hu G; Cheng Z Xenobiotica; 2011 Oct; 41(10):844-50. PubMed ID: 21679010 [TBL] [Abstract][Full Text] [Related]
19. Identification of human cytochrome P450 isoforms involved in the 7-hydroxylation of chlorpromazine by human liver microsomes. Yoshii K; Kobayashi K; Tsumuji M; Tani M; Shimada N; Chiba K Life Sci; 2000; 67(2):175-84. PubMed ID: 10901285 [TBL] [Abstract][Full Text] [Related]
20. Identification of the human liver cytochrome P450 isoenzyme responsible for the 6-methylhydroxylation of the novel anticancer drug 5,6-dimethylxanthenone-4-acetic acid. Zhou S; Paxton JW; Tingle MD; Kestell P Drug Metab Dispos; 2000 Dec; 28(12):1449-56. PubMed ID: 11095582 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]